Hypermethylation of the RASSF1A gene promoter region in lung cancer disrupts RASSF1A’s tumor suppressor function, potentially leading to dysregulated cell cycle progression and resistance to Ras-induced apoptosis. The gene discussed is RASSF1; the disease is lung carcinoma.